# Safety and Efficacy of Topical Cantharidin for the Treatment of Molluscum Contagiosum, Phase 2

> **NCT03017846** · PHASE2 · COMPLETED · sponsor: **Steven R Cohen** · enrollment: 30 (actual)

## Conditions studied

- Molluscum Contagiosum

## Interventions

- **DRUG:** Cantharidin

## Key facts

- **NCT ID:** NCT03017846
- **Lead sponsor:** Steven R Cohen
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09
- **Primary completion:** 2017-09-06
- **Final completion:** 2017-09-06
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2019-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03017846

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03017846, "Safety and Efficacy of Topical Cantharidin for the Treatment of Molluscum Contagiosum, Phase 2". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03017846. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*